Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Reduction in severity of a herpes simplex virus type 1 murine infection by treatment with a ribozyme targeting the UL20 gene RNA.

Liu J, Lewin AS, Tuli SS, Ghivizzani SC, Schultz GS, Bloom DC.

J Virol. 2008 Aug;82(15):7467-74. doi: 10.1128/JVI.02720-07. Epub 2008 May 28.

2.

Replication-Competent Controlled Herpes Simplex Virus.

Bloom DC, Feller J, McAnany P, Vilaboa N, Voellmy R.

J Virol. 2015 Oct;89(20):10668-79. doi: 10.1128/JVI.01667-15. Epub 2015 Aug 12.

3.

Spread of herpes simplex virus to the spinal cord is independent of spread to dorsal root ganglia.

Ohashi M, Bertke AS, Patel A, Krause PR.

J Virol. 2011 Mar;85(6):3030-2. doi: 10.1128/JVI.02426-10. Epub 2010 Dec 15.

4.
6.

Ribozyme gene therapy for hepatitis C virus infection.

Welch PJ, Yei S, Barber JR.

Clin Diagn Virol. 1998 Jul 15;10(2-3):163-71.

PMID:
9741642
7.
8.

Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.

Wang K, Mahalingam G, Hoover SE, Mont EK, Holland SM, Cohen JI, Straus SE.

J Virol. 2007 Jul;81(13):6817-26. Epub 2007 Apr 25.

10.

Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-beta.

Al-Khatib K, Williams BR, Silverman RH, Halford WP, Carr DJ.

J Interferon Cytokine Res. 2002 Aug;22(8):861-71.

PMID:
12396725
11.

[Adenovirus-mediated transfer of anti-MDR1 ribozyme in the treatment of multidrug-resistant human lymphoma in SCID mice].

Xu D, Wang F, Ohnuma T, Jin L.

Zhonghua Zhong Liu Za Zhi. 2002 Nov;24(6):529-32. Chinese.

PMID:
12667317
12.

Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.

Huang WY, Su YH, Yao HW, Ling P, Tung YY, Chen SH, Wang X, Chen SH.

J Gen Virol. 2010 Mar;91(Pt 3):591-8. doi: 10.1099/vir.0.016964-0. Epub 2009 Nov 11.

PMID:
19906941
16.
17.

Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.

Ghiasi H, Osorio Y, Hedvat Y, Perng GC, Nesburn AB, Wechsler SL.

Virology. 2002 Oct 10;302(1):144-54.

19.

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.

Crute JJ, Grygon CA, Hargrave KD, Simoneau B, Faucher AM, Bolger G, Kibler P, Liuzzi M, Cordingley MG.

Nat Med. 2002 Apr;8(4):386-91.

PMID:
11927945
20.

Construction of a novel oncolytic adenoviral vector and its biological characteristics.

Zhang M, Zhang X, Han Z, Chen X, Yang L, Sheng Y, Wen J.

Oncol Rep. 2013 Feb;29(2):798-804. doi: 10.3892/or.2012.2140. Epub 2012 Nov 15.

PMID:
23165979

Supplemental Content

Support Center